Dear Duchenne Community, We are pleased to share a meaningful update on the INSPIRE DUCHENNE clinical study, our multi-center, open-label clinical trial evaluating SGT-003, our investigational gene therapy for the treatment of Duchenne muscular dystrophy. As of August 12, 2025, 15 patients living with Duchenne have received SGT-003 in this study. The trial now includes ... Read more| Solid Biosciences